Editorial
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Diabetes. Jan 15, 2025; 16(1): 100376
Published online Jan 15, 2025. doi: 10.4239/wjd.v16.i1.100376
Influence of gut bacteria on type 2 diabetes: Mechanisms and therapeutic strategy
Xue Wen, Lu-Ming Qi, Kui Zhao
Xue Wen, Lu-Ming Qi, College of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu 610000, Sichuan Province, China
Kui Zhao, College of Materials and Chemical Engineering, Southwest Forestry University, Kunming 650224, Yunnan Province, China
Co-corresponding authors: Lu-Ming Qi and Kui Zhao.
Author contributions: Wen X designed and wrote the manuscript; Qi LM supervised the guidance of the manuscript; Zhao K provided financial support for this work; all of the authors read and approved the final version of the manuscript to be published.
Supported by "Caiyun Postdoctoral Program" of Innovation Project, 2023.
Conflict-of-interest statement: All other authors declare no competing interests.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Kui Zhao, PhD, Associate Professor, Research Scientist, Senior Scientist, College of Materials and Chemical Engineering, Southwest Forestry University, No. 300 White Dragon Temple, Panlong District, Kunming 650224, Yunnan Province, China. zhao10028tcm@126.com
Received: August 14, 2024
Revised: October 20, 2024
Accepted: November 8, 2024
Published online: January 15, 2025
Processing time: 107 Days and 12.8 Hours
Core Tip

Core Tip: Our editorial uncovers the pivotal role of the gut microbiome in type 2 diabetes mellitus (T2DM), pinpointing microbial imbalances as therapeutic targets. It explores the mechanisms behind the cross-tissue effects of gut bacteria on T2DM and its complications, suggesting that probiotics, prebiotics or fecal transplantation may offer a promising new path to combat this escalating global health issue.